Additional studies in progress advise that ARV-825 may also be effective in improving the response to estrogen deprivation (aromatase inhibition), another ingredient of standard of care in ER+ breast cancer. Celastrol was discovered being a Myb inhibitor that suppressed C/EBPβ activity and repressed AML cell proliferation in the Major mouse https://claytonxkugs.aboutyoublog.com/34666370/the-2-minute-rule-for-abbv-744-and-other-brd4-inhibitors-comparison